Testimony and Correspondence
Through its committees on Practice, Government Affairs, and Scientific Affairs, ASH formulates positions on pending federal legislation, regulations, and private insurance developments, which are communicated through congressional testimony and formal correspondence. In addition, ASH may submit comments to other organizations and governing bodies on issues related to research, practice, training, or quality of care issues affecting hematologists and their patients.
ASH Endorses Statement Opposing Texas Legislation Threatening Access to Patient Care
ASH Letter on FDAs Draft Guidance on Cancer Clinical Trial Eligibility Criteria
ASH Submits Letter to the FDA Regarding the Draft Guidance on PROs in Cancer Care